Literature DB >> 6975684

Disordered immune homeostasis in chronic idiopathic thrombocytopenic purpura.

R J Trent, R L Clancy, V Danis, A Basten.   

Abstract

A T:B co-culture system was used to test for the presence of disordered immune homeostasis in the autoimmune disease, chronic idiopathic thrombocytopenic purpura (ITP). Various numbers of T cells were added to a fixed number of B cells in the presence or absence of the polyclonal activator, pokeweed mitogen, and IgG production measured in the culture supernatants 6 days later. The results demonstrated a defect in T cell-dependent suppression and/or a state of B cell hyper-responsiveness in lymphocytes from patients compared to normal controls. The loss of T cell-dependent suppression could not be readily explained in terms of the therapy being used nor by the presence of circulating IgG containing immune complexes. The findings of a similar abnormality in some cases of non-immune thrombocytopenia suggested that the reduction in suppression observed in chronic ITP was unlikely to be a primary event in disease pathogenesis, although it could well contribute to the ongoing autoimmune response.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6975684      PMCID: PMC1537238     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  19 in total

1.  Quantitation of platelet-binding IgG produced in vitro by spleens from patients with idiopathic thrombocytopenic purpura.

Authors:  R McMillan; R L Longmire; R Yelenosky; R L Donnell; S Armstrong
Journal:  N Engl J Med       Date:  1974-10-17       Impact factor: 91.245

2.  Cellular immunity to autologous platelets and serum-blocking factors in idiopathic thrombocytopenic purpura.

Authors:  R Clancy
Journal:  Lancet       Date:  1972-01-01       Impact factor: 79.321

Review 3.  Human histocompatibility antigens of leukocytes.

Authors:  P I Terasaki; D P Singal
Journal:  Annu Rev Med       Date:  1969       Impact factor: 13.739

4.  Lymphocyte transformation induced by autologous platelets in a case of thrombocytopenic purpura.

Authors:  W F Piessens; J Wybran; J Manaster; P A Strijckmans
Journal:  Blood       Date:  1970-10       Impact factor: 22.113

5.  Similarities between known antiplatelet antibodies and the factor responsible for thrombocytopenia in idiopathic purpura. Physiologic, serologic and isotopic studies.

Authors:  N R Shulman; V J Marder; R S Weinrach
Journal:  Ann N Y Acad Sci       Date:  1965-06-30       Impact factor: 5.691

Review 6.  Autoimmune thrombocytopenic purpura.

Authors:  S Karpatkin
Journal:  Blood       Date:  1980-09       Impact factor: 22.113

7.  Immunodeficiency and grouping with thyrogastric autoimmune disease in patients with chronic idiopathic thrombocytopenic purpura.

Authors:  R L Clancy; H K Muller; H A Ward
Journal:  Aust N Z J Med       Date:  1974-06

8.  Analysis of parameters affecting the solid phase radioimmunoassay quantitation of antibody to meningococcal antigens.

Authors:  W D Zollinger; J M Dalrymple; M S Artenstein
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

Review 9.  Idiopathic thrombocytopenic purpura and the ITP syndrome.

Authors:  M G Baldini
Journal:  Med Clin North Am       Date:  1972-01       Impact factor: 5.456

10.  C1q deviation test for the detection of immune complexes, aggregates of IgG, and bacterial products in human serum.

Authors:  A T Sobel; V A Bokisch; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1975-07-01       Impact factor: 14.307

View more
  2 in total

1.  Transient disappearance of immunologic disorders and remission after intercurrent measles infections in children with chronic idiopathic thrombocytopenic purpura.

Authors:  C Y Lin; M T Lin; Y L Hsieh; L Y Tsao
Journal:  J Clin Immunol       Date:  1988-05       Impact factor: 8.317

2.  Regulation of human gut B lymphocytes by T lymphocytes.

Authors:  R Clancy; A Cripps; H Chipchase
Journal:  Gut       Date:  1984-01       Impact factor: 23.059

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.